Related Experiment Video
Updated: Sep 23, 2025

Simple and Fast Rolling Circle Amplification-Based Detection of Topoisomerase 1 Activity in Crude Biological Samples
Published on: December 2, 2022
Topoisomerase II poisons inhibit vertebrate DNA replication through distinct mechanisms
Sabrina X Van Ravenstein1, Kavi P Mehta1, Tamar Kavlashvili1
1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, USA.
Abstract:
Topoisomerase II (TOP2) unlinks chromosomes during vertebrate DNA replication. TOP2 "poisons" are widely used chemotherapeutics that stabilize TOP2 complexes on DNA, leading to cytotoxic DNA breaks. However, it is unclear how these drugs affect DNA replication, which is a major target of TOP2 poisons. Using Xenopus egg extracts, we show that the TOP2 poisons etoposide and doxorubicin both inhibit DNA replication through different mechanisms. Etoposide induces TOP2-dependent DNA breaks and TOP2-dependent fork stalling by trapping TOP2 behind replication forks. In contrast, doxorubicin does not lead to appreciable break formation and instead intercalates into parental DNA to stall replication forks independently of TOP2. In human cells, etoposide stalls forks in a TOP2-dependent manner, while doxorubicin stalls forks independently of TOP2. However, both drugs exhibit TOP2-dependent cytotoxicity. Thus, etoposide and doxorubicin inhibit DNA replication through distinct mechanisms despite shared genetic requirements for cytotoxicity.
Insights
Topoisomerase II (TOP2) poisons like etoposide and doxorubicin inhibit DNA replication via distinct mechanisms. Etoposide causes TOP2-dependent DNA breaks and stalling, while doxorubicin causes independent stalling, yet both are TOP2-dependent for cytotoxicity.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Topoisomerase II (TOP2) is crucial for unlinking chromosomes during DNA replication in vertebrates.
- TOP2 poisons are chemotherapeutics that stabilize TOP2-DNA complexes, causing DNA breaks and cytotoxicity.
- The precise impact of TOP2 poisons on DNA replication remains incompletely understood.
Purpose of the Study:
- To elucidate the distinct mechanisms by which etoposide and doxorubicin inhibit DNA replication.
- To investigate the role of TOP2 in the DNA replication inhibitory effects of these chemotherapeutics.
- To understand the shared and distinct pathways leading to cytotoxicity.
Main Methods:
- Utilized Xenopus egg extracts to study DNA replication dynamics.
- Employed etoposide and doxorubicin as model TOP2 poisons.
- Analyzed replication fork stalling and DNA break formation in vitro and in human cells.
Main Results:
- Etoposide induces TOP2-dependent DNA breaks and stalls replication forks by trapping TOP2 behind them.
- Doxorubicin intercalates into DNA, stalling replication forks independently of TOP2 and without significant break formation.
- Both drugs demonstrate TOP2-dependent cytotoxicity in human cells, despite differing replication inhibition mechanisms.
Conclusions:
- Etoposide and doxorubicin inhibit DNA replication through separate pathways.
- Replication fork stalling mechanisms differ between etoposide and doxorubicin.
- Despite distinct modes of action on replication, both drugs rely on TOP2 for their cytotoxic effects.
More Related Videos
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Drugs that Destabilize Microtubules
Restarting Stalled Replication Forks
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
DNA Damage can Stall the Cell Cycle

